Gilead Sciences Inc
GILD Real Time Price USD$GILD is featured in our Rob Bresnahan and Shelley Moore Capito strategies.
All StrategiesRecent trades of GILD by members of U.S. Congress
|
Name
|
Type
|
Shares
|
Price
|
Shares Held
|
Date
|
Reported
|
|---|
|
Investor
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
|
Investor
|
Type
|
Shares
|
Change in Shares
|
Market Value
|
Date
|
Reported
|
|---|
Recently reported changes in GILD holdings by institutional investors
Quarterly net insider trading by GILD's directors and management
* Insider trading data parsed from SEC Form 4 filings by Quiver Quantitative. Sign up for the Quiver API for real-time access.
- 1M
- 3M
- 6M
- YTD
- 1Y
- 2Y
- 5Y
- MAX
About
Key Metrics
Return (1d)
Return (30d)
Return (1Y)
CAGR (Total)
Max Drawdown
Beta
Alpha
Sharpe Ratio
Win Rate
Average Win
Average Loss
Annual Volatility
Annual Std Dev
Information Ratio
Treynor Ratio
Total Trades
Metrics Definitions
Disclaimer: The performance results shown are based on historical backtesting and are hypothetical in nature. Backtested performance does not represent actual trading and does not account for all market factors that may affect execution, such as liquidity, slippage, and changing market conditions. Past performance is not necessarily indicative of future results. There is no guarantee that any trading strategy will be profitable or avoid losses.
-
Alpha
Measures a portfolio's risk-adjusted performance against that of its benchmark
Learn More -
Annual Standard Deviation
Measures how much the portfolio's total return varies from its mean or average.
Learn More -
Annual Volatility
A statistical measure of the dispersion of returns for the portfolio.
Learn More -
Average Win
The average return (%) for trades that resulted in a positive return.
-
Average Loss
The average return (%) for trades that resulted in a negative return.
-
Beta
A measure of the volatility of the portfolio compared to the market as a whole.
Learn More -
CAGR
CAGR (Compounded Annual Growth Rate), is the historical annualized rate of return for an investment strategy, throughout the backtest period.
Learn More -
Information Ratio
A measurement of portfolio returns beyond the returns of its benchmark compared to the volatility of those returns.
Learn More -
Max Drawdown
the maximum observed loss from a peak to a trough of a portfolio, before a new peak is attained.
Learn More -
Sharpe Ratio
The Sharpe Ratio is a measure of historical risk-adjusted return, which quantifies the amount of return that an investor received per unit of risk.
Learn More -
Total Trades
The total number of trades made by this strategy.
-
Treynor Ratio
Attempts to measure how successful an investment is in providing compensation to investors for taking on investment risk.
Learn More -
Win Rate
The percentage of total trades that resulted in a positive return.
Be the first to see our newest insights and key updates across all datasets.
Government lobbying spending instances
-
$2,780,000 Oct 20, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
-
$1,700,000 Jul 21, 2025 Issue: Health Issues Trade (domestic/foreign) Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
-
$1,662,000 Apr 21, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
-
$2,440,000 Jan 21, 2025 Issue: Trade (domestic/foreign) Health Issues Medicare/Medicaid Copyright/Patent/Trademark Budget/Appropriations Taxation/Internal Revenue Code
-
$2,050,000 Oct 21, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$1,530,000 Jul 22, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$2,740,000 Apr 18, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$1,680,000 Jan 23, 2024 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$2,390,000 Oct 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$1,440,000 Jul 20, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$1,490,000 Apr 14, 2023 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$2,520,000 Oct 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$1,372,000 Jul 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$2,620,000 Apr 20, 2022 Issue: Taxation/Internal Revenue Code Budget/Appropriations Copyright/Patent/Trademark Medicare/Medicaid Health Issues Trade (domestic/foreign)
-
$1,980,000 Jan 19, 2022 Issue: None
-
$2,290,000 Oct 20, 2021 Issue: None
-
$1,380,000 Jul 20, 2021 Issue: None
-
$2,530,000 Apr 20, 2021 Issue: None
-
$1,510,000 Jan 20, 2021 Issue: None
-
$1,810,000 Oct 20, 2020 Issue: None
-
$1,260,000 Jul 20, 2020 Issue: None
-
$2,450,000 Apr 20, 2020 Issue: None
-
$1,300,000 Jan 21, 2020 Issue: None
-
$1,480,000 Oct 21, 2019 Issue: Budget/Appropriations Medicare/Medicaid Veterans Health Issues Taxation/Internal Revenue Code Copyright/Patent/Trademark Trade (domestic/foreign)
-
$1,080,000 Jul 22, 2019 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code
-
$1,860,000 Apr 23, 2019 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Trade (domestic/foreign) Taxation/Internal Revenue Code Veterans Copyright/Patent/Trademark Health Issues
-
$700,000 Jan 22, 2019 Issue: Medicare/Medicaid Defense Trade (domestic/foreign) Copyright/Patent/Trademark Health Issues Veterans Budget/Appropriations Indian/Native American Affairs Taxation/Internal Revenue Code
-
$680,000 Oct 22, 2018 Issue: Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Trade (domestic/foreign) Indian/Native American Affairs Budget/Appropriations
-
$800,000 Jul 20, 2018 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Taxation/Internal Revenue Code Veterans Trade (domestic/foreign)
-
$810,000 Apr 20, 2018 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Veterans Foreign Relations Indian/Native American Affairs Budget/Appropriations Taxation/Internal Revenue Code
-
$900,000 Jan 22, 2018 Issue: Indian/Native American Affairs Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign) Taxation/Internal Revenue Code Veterans Foreign Relations
-
$810,000 Oct 20, 2017 Issue: Budget/Appropriations Medicare/Medicaid Health Issues Veterans Copyright/Patent/Trademark Foreign Relations Trade (domestic/foreign) Taxation/Internal Revenue Code Pharmacy Indian/Native American Affairs
-
$790,000 Jul 20, 2017 Issue: Pharmacy Budget/Appropriations Medicare/Medicaid Health Issues Copyright/Patent/Trademark Veterans Trade (domestic/foreign) Indian/Native American Affairs Foreign Relations Taxation/Internal Revenue Code
-
$1,050,000 Apr 20, 2017 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Medicare/Medicaid Foreign Relations Health Issues Copyright/Patent/Trademark Indian/Native American Affairs Veterans Trade (domestic/foreign) Taxation/Internal Revenue Code Budget/Appropriations
-
$960,000 Jan 19, 2017 Issue: Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Budget/Appropriations Foreign Relations Trade (domestic/foreign) Law Enforcement/Crime/Criminal Justice Pharmacy
-
$780,000 Oct 20, 2016 Issue: Law Enforcement/Crime/Criminal Justice Pharmacy Medicare/Medicaid Foreign Relations Veterans Health Issues Copyright/Patent/Trademark Budget/Appropriations Trade (domestic/foreign) Defense
-
$760,000 Jul 19, 2016 Issue: Medicare/Medicaid Foreign Relations Health Issues Pharmacy Trade (domestic/foreign) Veterans Defense Budget/Appropriations Copyright/Patent/Trademark
-
$980,000 Apr 18, 2016 Issue: Science/Technology Pharmacy Medicare/Medicaid Foreign Relations Veterans Health Issues Trade (domestic/foreign) Defense Budget/Appropriations Copyright/Patent/Trademark
-
$890,000 Jan 20, 2016 Issue: Science/Technology Pharmacy Medicare/Medicaid Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark Veterans Foreign Relations Defense Budget/Appropriations
-
$700,000 Oct 19, 2015 Issue: Pharmacy Medicare/Medicaid Veterans Health Issues Defense Trade (domestic/foreign) Foreign Relations Budget/Appropriations Copyright/Patent/Trademark Science/Technology
-
$550,000 Jul 20, 2015 Issue: Science/Technology Pharmacy Medicare/Medicaid Veterans Health Issues Copyright/Patent/Trademark Defense Foreign Relations Budget/Appropriations Trade (domestic/foreign)
-
$800,000 Apr 21, 2015 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Defense Copyright/Patent/Trademark
-
$620,000 Jan 19, 2015 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Defense Copyright/Patent/Trademark
-
$640,000 Oct 17, 2014 Issue: Medicare/Medicaid Health Issues Veterans Trade (domestic/foreign) Copyright/Patent/Trademark
-
$820,000 Jul 15, 2014 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$810,000 Apr 18, 2014 Issue: Medicare/Medicaid Veterans Health Issues Trade (domestic/foreign) Copyright/Patent/Trademark
-
$550,000 Jan 21, 2014 Issue: Health Issues Copyright/Patent/Trademark Veterans Medicare/Medicaid
-
$540,000 Oct 21, 2013 Issue: Health Issues Copyright/Patent/Trademark Veterans Medicare/Medicaid
-
$623,000 Aug 05, 2013 Issue: Health Issues Copyright/Patent/Trademark
-
$510,000 Jul 19, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark Trade (domestic/foreign)
-
$320,000 Jan 22, 2013 Issue: Medicare/Medicaid Health Issues Copyright/Patent/Trademark
-
$370,000 Oct 22, 2012 Issue: Health Issues
-
$340,000 Jul 20, 2012 Issue: Health Issues
-
$560,000 Apr 20, 2012 Issue: Health Issues
-
$400,000 Jan 20, 2012 Issue: Health Issues
-
$370,000 Oct 20, 2011 Issue: Health Issues
-
$390,000 Jul 20, 2011 Issue: Health Issues
-
$500,000 Apr 20, 2011 Issue: Health Issues
-
$340,000 Jan 20, 2011 Issue: Health Issues
-
$350,000 Oct 20, 2010 Issue: Health Issues
-
$350,000 Jul 20, 2010 Issue: Health Issues
-
$480,000 Apr 20, 2010 Issue: Health Issues
-
$370,000 Jan 20, 2010 Issue: Health Issues
-
$350,000 Oct 20, 2009 Issue: Health Issues
-
$290,000 Jul 20, 2009 Issue: Health Issues
-
$270,000 Apr 20, 2009 Issue: Health Issues
-
$240,000 Jan 09, 2009 Issue: Health Issues
-
$240,000 Oct 28, 2008 Issue: Health Issues
-
$260,000 Oct 28, 2008 Issue: Health Issues
-
$260,000 Jun 25, 2008 Issue: Health Issues
-
$280,000 Feb 14, 2008 Issue: Health Issues
-
$380,000 Aug 14, 2007 Issue: Health Issues
-
$355,000 Feb 13, 2007 Issue: Health Issues
-
$455,000 Aug 14, 2006 Issue: Health Issues
-
$180,000 Apr 06, 2006 Issue: Health Issues
-
$60,000 Aug 24, 2005 Issue: Medical/Disease Research/Clinical Labs
-
$140,000 Aug 22, 2005 Issue: Health Issues
-
$20,000 Aug 15, 2005 Issue: Trade (domestic/foreign)
-
$40,000 Feb 09, 2005 Issue: None
-
$40,000 Sep 08, 2004 Issue: Health Issues
-
$100,000 Apr 12, 2004 Issue: Health Issues Pharmacy
-
$100,000 Aug 15, 2003 Issue: Health Issues Pharmacy
-
$100,000 Mar 03, 2003 Issue: Health Issues Pharmacy
-
$100,000 Aug 14, 2002 Issue: Health Issues Pharmacy
-
$60,000 Feb 14, 2002 Issue: Health Issues Pharmacy
GILD Estimated quarterly lobbying spending
GILD Revenue by Segment or Geography
New GILD patent grants
-
Patent Title: Blister pack Sep. 23, 2025
-
Patent Title: Blister pack Aug. 05, 2025
-
Patent Title: Pouch Jul. 29, 2025
-
Patent Title: Carton Jun. 17, 2025
-
Patent Title: Blister pack May. 20, 2025
-
Patent Title: Blister pack Mar. 04, 2025
-
Patent Title: Blister pack Feb. 25, 2025
-
Patent Title: Blister pack May. 28, 2024
-
Patent Title: Blister pack May. 21, 2024
-
Patent Title: Pharmaceutical package Mar. 26, 2024
-
Patent Title: Pharmaceutical package Mar. 05, 2024
-
Patent Title: Blister pack May. 09, 2023
-
Patent Title: Blister pack May. 09, 2023
-
Patent Title: Blister pack packaging blank Feb. 28, 2023
-
Patent Title: Blister pack Dec. 27, 2022
-
Patent Title: Blister pack Dec. 27, 2022
-
Patent Title: Blister pack Aug. 23, 2022
-
Patent Title: Blister pack Aug. 16, 2022
-
Patent Title: Pharmaceutical package Jul. 26, 2022
-
Patent Title: Pharmaceutical package Jul. 26, 2022
-
Patent Title: Pharmaceutical package Jun. 21, 2022
-
Patent Title: Apoptosis signal-regulating kinase inhibitors Aug. 31, 2021
-
Patent Title: Apoptosis signal-regulating kinase inhibitors Aug. 11, 2020
-
Patent Title: 2-(n-pyrazolo)adenosines with application as adenosine a Apr. 16, 2019
-
Patent Title: Macrocyclic inhibitors of flaviviridae viruses Apr. 02, 2019
-
Patent Title: Process for preparing an a2a-adenosine receptor agonist and its polymorphs Mar. 19, 2019
-
Patent Title: Method for treating a pulmonary hypertension condition Jun. 12, 2018
-
Patent Title: 2′-chloro aminopyrimidinone and pyrimidine dione nucleosides May. 29, 2018
-
Patent Title: Methods for treating cancers May. 22, 2018
-
Patent Title: Substituted imidazo[1,2-a]pyrazines as syk inhibitors May. 15, 2018
-
Patent Title: Pyrazolo[1,5-a]pyrimidines for antiviral treatment May. 01, 2018
-
Patent Title: Benzimidazole and imadazopyridine carboximidamide compounds Apr. 24, 2018
-
Patent Title: Therapeutic compounds Apr. 24, 2018
-
Patent Title: Methods for treating Apr. 24, 2018
-
Patent Title: Compounds for the treatment of hiv Apr. 17, 2018
-
Patent Title: Apoptosis signal-regulating kinase inhibitors Apr. 17, 2018
-
Patent Title: Fxr (nr1h4) modulating compounds Apr. 10, 2018
-
Patent Title: Fxr (nr1h4) modulating compounds Apr. 03, 2018
-
Patent Title: Syk inhibitors Apr. 03, 2018
-
Patent Title: 1′-substituted carba-nucleoside analogs for antiviral treatment Mar. 27, 2018
-
Patent Title: Fused heterocyclic compounds as ion channel modulators Mar. 20, 2018
-
Patent Title: Apoptosis signal-regulating kinase inhibitors Mar. 06, 2018
-
Patent Title: Solid forms of an ask1 inhibitor Mar. 06, 2018
-
Patent Title: Modulators of pharmacokinetic properties of therapeutics Feb. 13, 2018
-
Patent Title: Therapeutic compounds Jan. 30, 2018
-
Patent Title: Cot modulators and methods of use thereof Jan. 30, 2018
-
Patent Title: Macrocyclic inhibitors of flaviviridae viruses Jan. 23, 2018
-
Patent Title: Apoptosis signal-regulating kinase inhibitor Jan. 23, 2018
-
Patent Title: Therapeutic compounds Jan. 23, 2018
-
Patent Title: Crystalline forms of an antiviral compound Jan. 09, 2018
Federal grants, loans, and purchases
- $14,894 2025-05-14 00:00:00 Agency: Department of Veterans Affairs
- $3,882 2025-01-28 00:00:00 Agency: Department of Veterans Affairs
- $3,106 2025-01-23 00:00:00 Agency: Department of Veterans Affairs
- $14,938 2024-09-12 00:00:00 Agency: Department of Veterans Affairs
- $47,797 2024-06-26 00:00:00 Agency: Department of Veterans Affairs
- $47,797 2024-06-06 00:00:00 Agency: Department of Veterans Affairs
- $14,938 2024-04-15 00:00:00 Agency: Department of Veterans Affairs
- $307,511 2023-10-05 00:00:00 Agency: Department of Veterans Affairs
- $0 2022-09-27 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $287,923 2022-08-05 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $393,105 2022-07-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $38,673 2021-12-30 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $19,337 2021-12-23 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-09-24 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $19,337 2021-09-10 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-07-29 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $373,000 2021-07-13 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $34,806 2021-07-02 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-06-01 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-04-26 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-03-16 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $77,850 2021-03-02 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $46,710 2021-02-24 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $58,388 2021-02-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-02-02 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $77,850 2021-01-21 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $3,892,500 2021-01-20 00:00:00 Agency: DEPARTMENT OF HEALTH AND HUMAN SERVICES (HHS)
- $136,238 2021-01-19 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $284,905 2021-01-15 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $46,710 2021-01-12 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $194,625 2021-01-11 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $77,850 2021-01-08 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $155,700 2021-01-06 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
- $46,710 2021-01-05 00:00:00 Agency: DEPARTMENT OF VETERANS AFFAIRS (VA)
Estimated quarterly amount awarded to GILD from public contracts
Recent insights relating to GILD
Recent picks made for GILD stock on CNBC
ETFs with the largest estimated holdings in GILD
- ... Highest Price Target
- ... Median Price Target
- ... Lowest Price Target
|
Analyst
|
Firm
|
Current
|
Previous
|
Date
|
|---|
- Is $GILD stock a Buy, Sell, or Hold?
- What is the price target for $GILD stock?
* Analyst consensus is not financial advice. Please see our data disclaimers .
|
Shareholder
|
Shares Held
|
|---|
- Who owns $GILD stock?
- Who owns the most shares of $GILD stock?
- What funds own $GILD stock?
* These are estimates based on data taken from SEC filings. There may be inaccuracies due to parsing errors, accidental double-counting, incorrect classification of indirectly owned shares, or any other number of issues.
The Quiver Smart Score combines our data on Congress Trading, Lobbying, Insider Trading, CNBC Mentions and more to provide a comprehensive view of the strength of a stock's underlying data.
The Smart Score grades stocks on a scale of 1 (weakest) to 10 (strongest) based on the strength of the underlying data.Sign Up to view GILD Smart Score
See concise summaries of analyst reports, presenting both bullish and bearish arguments for a stock.
Example:
The Bulls Say summary highlights positive aspects of the stock.
The Bears Say summary points out potential risks and negative aspects of the stock.
Gilead Sciences develops and markets therapies to treat and prevent life-threatening infectious diseases, with the core of its portfolio focused on HIV and hepatitis B and C. Gilead's acquisition of Pharmasset brought rights to hepatitis C drug Sovaldi, which is also part of newer combination regimens that remain standards of care. Gilead is also growing its presence in the oncology market via acquisitions, led by CAR-T cell therapy Yescarta/Tecartus (from Kite) and breast and bladder cancer therapy Trodelvy (from Immunomedics).
- Address Foster City, CA
- Market Cap 152.1 billion
- Employees 17,600
- Industrial Classification Biological Products, (No Disgnostic Substances)